E N D
1. Continuous Quality Improvement in Diabetes Care Julie Day, MD – Medical Director for Quality
Annie Mervis, MSW – Quality Manager
University of Utah Health Care: Community Clinics
Diabetes Telehealth Series
October 15, 2008
2. UUHC Community Clinics 10 clinics
70 primary care providers
25 specialists
550 support staff
215,000 primary care visits (annually)
110,000 active patients (18 months)
4500–5000 patient with diabetes (annually)
4. Presentation Objectives At the end of this presentation, participants will have an understanding of
Continuous quality improvement tools and processes and how these were applied to improve diabetes care
the importance of data in evaluating effectiveness of interventions
the need to continue through multiple cycles of the Plan, Do, Study, Act cycle of improvement
5. Presentation Overview Key QI concepts and differences
Review of FOCUS-PDSA cycle
Case study demonstrating how we applied the process and tools
Results
What we learned
Our next steps
6. Key QI Concepts Improving work processes
Quality is everyone’s job
Teams and teamwork are critical
People doing the job know best how to improve it
QI uses a systematic approach to analyze opportunities and design changes to drive improvement
Meeting and exceeding customer expectations
New Mexico IN-FOCUS Teleconference Series, The Nuts and Bolts of QI, New Mexico Medical Review Association
7. Differences between QA and QI
8. FOCUS-PDSA Focus – Find an opportunity to improve
Organize a team
Clarify understanding of process needing improvement
Understand variation, root causes, and barriers
Select an opportunity and strategy
Plan intervention
Do intervention
Study the results
Act to hold the gains or continue to improve on
9. Find an opportunity FOCUS-PDSA
11. Why? National priority from 2003 Institute of Medicine Report
UUHC priority set by Board of Directors
Impact on patient quality of life (misery index)
Ability to successfully intervene in an outpatient setting
12. Organize a team FOCUS-PDSA
13. The Diabetes Quality Group Includes:
3 Patients
7 Providers
3 Health Educators
2 HealthInsight staff
1 Epic and 1 Data Support staff
2 Support staff
1 Health Plan staff
14. Aim Statement Over the next 12 months we will improve care by:
Identifying our diabetic population
Establishing targets for selected diabetic parameters
Devising appropriate interventions to enable us to meet our improvement goals for our diabetic population
15. Clarify understanding of the process FOCUS-PDSA
16. Baseline Data and Goals for Improvement Measure* Baseline (1/04) Initial Goal
HgbA1c ordered 2x annually 71% 85%
HgbA1c <7% 47% 62%
LDL <100 43% 60%
BP <130/80 28% 45%
Microalbumin ordered annually 54% 63%
*ADA, UHC
17. Process Flow Diagram
18. Process Analysis – Key Questions Are patients coming in regularly?
Are providers ordering needed tests according to guidelines?
Are patients following through with provider recommendations and taking ownership of self-management?
Are A1c, LDL and BP where patient and provider would like them to be?
19. Understand variation, root causes, and barriers FOCUS-PDSA
20. Cause and Effect Diagram
21. Select an opportunity and strategy FOCUS-PDSA
22. Barriers Patient: ownership and self-management
Providers: competing priorities
Process: variation between clinics
Environment: obesity increasing
Systems: not maximizing EMR capabilities
23. Plan an intervention and Do it FOCUS-PDSA
24. Interventions Provider CME – Feb 04
EMR-based tools to support providers in the exam room – Feb 04
Patient Awareness Materials – Feb 04
Monthly measurement and feedback to providers – Feb 04
Registries – May 04
Outreach letters to patients – May 04
25. Registry
26. Blood Sugar Control Chart
27. Feedback Reports at Clinic Level
28. Study the results FOCUS-PDSA
29. Process Results
30. Outcome Results
31. Results – PDSA Cycle 1
32. Act to hold gains or continue to improve FOCUS-PDSA
33. Next Steps Identify additional barriers that may be affecting improvement
Develop new interventions to address identified barriers
Expand population to include patients not see as regularly
Ongoing efforts sustain registry work
34. Plan PDSA Cycle 2
35. Project Overview – PDSA Cycle 2 Initiated July 2005
System-wide approach and interventions
Target population - patients with diabetes being seen less regularly
1 diabetes visit in 12 months
3,800 – 4,300 patients annually
Support for registry management
Patient self-efficacy and self-management
36. Baseline – PDSA Cycle 2
37. Barriers – PDSA Cycle 2 Registries
Inaccurate or out-dated PCPs
Patients followed elsewhere for diabetes care
Time and support for registry management
Barriers to enhanced self-management skills
Limited exam room time and time for visit planning
38. Do PDSA Cycle 2
39. Interventions – PDSA Cycle 2 Provider Training – Jul 05
On-site Diabetes Education Courses – Nov 05
Centralized Support for Registry Management – Feb 06
Provider feedback and flag on registry for patients followed elsewhere
PCP Assignment – MA workflow – Feb 06
Shared Medical Appointments – Feb 06
Screening for Depression (PHQ9) – Apr 06
40. Interventions – PDSA Cycle 2 Practice Redesign “Care by Design” - ongoing
Templates and workflows for Pre-Visit and Visit Planning (acute and chronic) – Oct 06
Patient Activation through mutual goal setting and motivational interviewing - Oct 06
System-wide Staff Development Institute
Templates for goal setting
Patient education information imbedded in EMR
“Pay for Performance” incentive plan to work registries - Jan 07
41. Study PDSA Cycle 2
42. Results – PDSA Cycle 2
43. Results – PDSA Cycle 2
44. Lessons Learned Provider and MA commitment to Shared Medical Appointments is critical to ongoing success
Registries and visit planning should be part of care process, not an add-ons
Incentive provides initial boost, but hard to sustain
Implementation of new tools and processes requires consistent (and constant) support and feedback
Need regular on-site support
More timely and meaningful feedback reports
45. Lessons Learned Hard to compare our performance to others when everyone uses different measurement definitions
Practice redesign (Care by Design) appears to support expanded care processes better than traditional model
Need to begin addressing need for cross-condition care, rather than condition-specific silos
46. Act PDSA Cycle 2
47. Next Steps Sustain the work started by centralized registry support and clinic incentives
Address time and competing priorities
Maintain accurate PCPs
Continue expansion of SMAs
Consistently implement “Care by Design” with visit planning processes and tools delivered by Care Teams in all 10 clinics
48. Plan PDSA Cycle 3
49. Project Overview – PDSA Cycle 3 Began participating in CMS Care Management Demonstration Project (P4P) in July 07
DM, CAD, HF, and Preventive Care
Project provided standardized definitions for 26 measures
We revised our quality reports to be consistent
Provided visibility and priority status for system-wide quality improvement and resource allocation
Initiated assessment of implementation status of Care by Design
Obtained resources to support SMAs and patient self-management
50. Baseline – PDSA Cycle 3
51. Barriers – PDSA Cycle 3 Registries
Quarterly paper registries cumbersome and not timely
Diabetes only - contributing to silos rather than integrated care
Registry work not a priority for clinic staff
Hard to keep track of everything needing to be done for each patient at the time of visit
Practice Redesign not fully implemented in every clinic
Visit planning tools and goal setting not being consistently utilized
No formalized process to assess implementation of Care by Design
52. Barriers – PDSA Cycle 3 Limited support for patient self-efficacy and self-management training
Performance feedback not provider specific
PCPs out-dated (again)
53. Do PDSA Cycle 3
54. Interventions – PDSA Cycle 3 Expanded Best Practice Alerts in EMR to support 26 key aspects of care – Jan 08
Evaluation of level of implementation of Care by Design – May 08
On-line clinic and provider feedback reports – Aug 08
Hired Practice Enhancement Coordinator – Sep 08
Oversight of registries and visit planning processes and tools
Patient self-management trainings
Shared Medical Appointments
On-line, multi-condition registry integrated at patient level – Oct 08
Un-blinded provider detail reports – Nov 08
55. Study PDSA Cycle 3
56. Measurement – PDSA Cycle 3 In progress now
CBD Implementation Status assessment
Team Survey
Measurement of Q indicators (new reports)
57. Summary Challenges:
Using EMR data in new ways than before
Changing measure definitions
Limited programming support slowed progress on reports and registries
Resources for vision and planning, but limited for implementation support across system
58. Summary Successes
Increased provider and staff awareness of quality improvement efforts
Some incremental improvement over time in traditional model
Preliminary data suggests Care by Design, when fully implemented, supports better care and outcomes
Preparation for the future if payors move to models of pay for performance
59. Questions? Contact Information
Julie Day, MD, Medical Director for Quality
University of Utah Health Care: Community Clinics
julie.day@hsc.utah.edu
(801) 587-6307
Annie Mervis, MSW, Quality Manager
University of Utah Health Care: Community Clinics
annie.mervis@hsc.utah.edu
(801) 587-6327